HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Post-Pandemic Stocks

1,364.927

+36.6442.76%

Number of Gainers:12

Number of Losers:4

Number of Flat:2

PE:- -

High:1,366.577

Open:1,327.980

Low:1,315.501

Close:1,328.283

Volume:225.14M

Turnover:2.53B

Market Cap:913.45B

Float Cap:765.28B

Loading ...

CSPC Pharma's HER2 Antibody Application Accepted, CR Sanjiu Secures Rare Disease Drug, Domestic CAR-T Goes Global for Over $860M

Sinopharm Group Stock Advances 4.0% in Hong Kong

HK Stock Movement | ASCLETIS-B (01672) Surges Over 7% in Late Trading as ASC36 Enters Clinical Development Phase, IND Application to Be Submitted in Q2 Next Year

CITIC Securities Maintains "Buy" Rating on SINOPHARM (01099), Q3 Performance in Line with Expectations

CMB International: CXO Sector Performance May Recover in H2, Favors SINO BIOPHARM and WUXI XDC

SINOPHARM (01099) Rises Over 3% to Hit Yearly High After Morgan Stanley Sets HK$22.5 Target Price

Insurance Sector Expands Ecosystem at 2025 CIIE: Top Insurers Collaborate with Industry Giants to Build New Industrial Chain

Is JD Health International Inc. (HKG:6618) Expensive For A Reason? A Look At Its Intrinsic Value

Simply Wall St.

HK Stock Connect Shareholding Changes | Nov 11

Ascletis Pharma (SEHK:1672) Is Up 5.5% After Revealing Promising Obesity Drug Updates at ObesityWeek 2025 Has The Bull Case Changed?

Simply Wall St.

BRIEF-Shanghai Junshi Biosciences Says As Of Nov 10 Chair Increased A Shares Shareholding

Shanghai Junshi Biosciences - as of Nov 10 Chair Increased a Shares Shareholding by 100,000 Shares Total Transaction Amount at RMB3.8 Mln

THOMSON REUTERS

CSPC Pharmaceutical Group Board to Approve Third Quarter Results

BYD Company Limited: Improved Per-Vehicle Profitability with Breakthroughs in Technology, Premiumization, and Exports

Ping An Implements "Three Foundations, Four Supports" Model to Empower Grassroots Healthcare

Sino Biopharmaceutical Stock Advances 1.8% in Hong Kong

CSPC Pharmaceutical Group Stock Rises 2.7% in Hong Kong, Outperforms Competitors

JD Health International Stock Climbs 3.3% in Hong Kong

CMB International: Healthcare Sector Favors Stable Strategies, Opportunities in Undervalued Stocks

CanSino Biologics to Use Reserves to Offset Accumulated 1.45 Billion Yuan Losses; Shares Gain 3%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK1515/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":1364.9266,"timestamp":1763091194614,"preClose":1328.283,"halted":0,"volume":225141773,"delay":0,"changeRate":0.027587,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":36.643677,"latestTime":"11-14 11:33:15","open":1327.9797,"high":1366.5773,"low":1315.5012,"amount":2527156798,"amplitude":0.038453,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1763092800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1763083800000,1763092800000],[1763096400000,1763107200000]],"pbRate":2.485043,"peRate":26.810125,"turnoverRate":0.003082,"increases":12,"decrements":4,"flats":1,"marketCap":913448512128,"floatMarketCap":765282833024},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":1366.5773,"amplitude":0.038453,"preClose":1328.283,"low":1315.5012,"pbRate":"2.485043","latestPrice":1364.9266,"volume":225141773,"delay":0,"open":1327.9797,"prevYearClose":787.97723,"prevWeekClose":1243.435,"prevMonthClose":1279.786,"prevQuarterClose":1449.838,"fiveDayClose":1243.435,"twentyDayClose":1394.582,"sixtyDayClose":1401.475,"secType":"PLATE","market":"HK","turnoverRate":0.003082,"peRate":26.810125,"marketCap":913448512128,"floatMarketCap":765282833024,"timestamp":1763091194614,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":12,"down":4,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1160217558","title":"CSPC Pharma's HER2 Antibody Application Accepted, CR Sanjiu Secures Rare Disease Drug, Domestic CAR-T Goes Global for Over $860M","url":"https://stock-news.laohu8.com/highlight/detail?id=1160217558","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160217558?lang=en_us&edition=fundamental","pubTime":"2025-11-11 20:01","pubTimestamp":1762862481,"startTime":"0","endTime":"0","summary":"CSPC Pharma's Pertuzumab Application Accepted   On November 11, the CDE website showed that CSPC Pharma's pertuzumab injection application for HER2-positive breast cancer treatment was accepted....","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1008478684.HKD","LU1951186391.HKD","SG9999004220.SGD","BK0175","LU1152091754.HKD","LU1226287529.USD","IE00B031HY20.USD","LU1152091168.USD","BK4022","IE00BZ08YR35.GBP","IE0008369823.USD","IE00B5MMRT66.SGD","IE00BZ08YT58.USD","LU1328277881.USD","LU1226287875.USD","BK4230","BK0012","BK1161","LU1807302812.USD","BK0188","LU1960683339.HKD","LU0326950275.SGD","LU1993786604.SGD","LU0314109678.HKD","LU0315179316.USD","BK1515","06978","LU0140636845.USD","LU1226288253.USD","IE00BZ08YS42.EUR","LU0067412154.USD","IE0008368742.USD","BK0028","BK0239","BK0010","000999","LU0880133367.SGD","LU1226288170.HKD","BK1191","01093","HK0000165453.HKD","LU2039709279.SGD","LU1813983027.USD","BK1574","IE00B543WZ88.USD","CAR","LU0501845795.SGD","BK0060","159992","BK0185","LU0072913022.USD","BK0183","LU1226287792.SGD","BK1521","BK0196"],"gpt_icon":0},{"id":"2582835938","title":"Sinopharm Group  Stock Advances 4.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2582835938","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582835938?lang=en_us&edition=fundamental","pubTime":"2025-11-11 16:30","pubTimestamp":1762849800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. rallied 4.0% to 20.88 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.2% to 26696.41.This was the stock's sixth consecutive day of gains.Sinopharm Group Co. Ltd. closed 6.6% below its 52-week high of HK$22.35, which the company achieved Dec. 16.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 0.3%.Trading volume totaled 12.7 million shares, compared to the 50-day average of 5.3 million shares.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","BK1500","LU0640798160.USD","LU1115378108.SGD","BK1197","SHTDY","01099","BK1515"],"gpt_icon":0},{"id":"1155120703","title":"HK Stock Movement | ASCLETIS-B (01672) Surges Over 7% in Late Trading as ASC36 Enters Clinical Development Phase, IND Application to Be Submitted in Q2 Next Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1155120703","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155120703?lang=en_us&edition=fundamental","pubTime":"2025-11-11 15:24","pubTimestamp":1762845854,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) surged over 7% in late trading, closing up 7.05% at HK$11.08 with a turnover of HK$59.94 million. The company recently announced the selection of ASC36, a potential \"best-in-class\"...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2153591404.USD","LU2348773727.SGD","LU2226123227.USD","BK1258","LU0149534421.HKD","01672","BK1229","LU1316543674.SGD","BK1161","LU0264606111.USD","LU0229494975.USD","01972","LU0572940350.SGD","LU2226123490.SGD","LU0607220059.USD","BK1191","BK1534","BK1574","LU1211504680.USD","BK1515","BK1601","LU0572939691.SGD","01477"],"gpt_icon":0},{"id":"1179158287","title":"CITIC Securities Maintains \"Buy\" Rating on SINOPHARM (01099), Q3 Performance in Line with Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=1179158287","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179158287?lang=en_us&edition=fundamental","pubTime":"2025-11-11 14:44","pubTimestamp":1762843496,"startTime":"0","endTime":"0","summary":"CITIC Securities released a research report maintaining a \"Buy\" rating on SINOPHARM (01099), with projected revenues of RMB 589.221 billion, RMB 619.591 billion, and RMB 651.789 billion for...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","LU0640798160.USD","LU1115378108.SGD","BK1197","01099","BK1515"],"gpt_icon":0},{"id":"1158115340","title":"CMB International: CXO Sector Performance May Recover in H2, Favors SINO BIOPHARM and WUXI XDC","url":"https://stock-news.laohu8.com/highlight/detail?id=1158115340","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158115340?lang=en_us&edition=fundamental","pubTime":"2025-11-11 14:30","pubTimestamp":1762842622,"startTime":"0","endTime":"0","summary":"CMB International released a research report stating that the MSCI China Healthcare Index has surged 59.5% year-to-date, outperforming the MSCI China Index by 24%. However, the healthcare sector has...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1521","BK1515","BK1141","01177","HK0000165453.HKD","IE00BZ08YS42.EUR","02268","IE00BZ08YT58.USD","LU2488822045.USD","BK1589","IE00BZ08YR35.GBP","SG9999014674.SGD","CXO"],"gpt_icon":0},{"id":"1137614652","title":"SINOPHARM (01099) Rises Over 3% to Hit Yearly High After Morgan Stanley Sets HK$22.5 Target Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1137614652","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137614652?lang=en_us&edition=fundamental","pubTime":"2025-11-11 11:58","pubTimestamp":1762833496,"startTime":"0","endTime":"0","summary":"SINOPHARM (01099) surged over 3%, reaching a yearly high of HK$20.86. At the time of writing, the stock was up 3.49% to HK$20.78, with a trading volume of HK$111.2 million. Previously in October,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","LU0640798160.USD","LU1115378108.SGD","BK1197","01099","BK1515"],"gpt_icon":0},{"id":"1152109656","title":"Insurance Sector Expands Ecosystem at 2025 CIIE: Top Insurers Collaborate with Industry Giants to Build New Industrial Chain","url":"https://stock-news.laohu8.com/highlight/detail?id=1152109656","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152109656?lang=en_us&edition=fundamental","pubTime":"2025-11-11 11:20","pubTimestamp":1762831247,"startTime":"0","endTime":"0","summary":"At the record-breaking 8th China International Import Expo (CIIE), domestic insurers are actively expanding their ecosystems through partnerships with global industry leaders, emerging as a highlight...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK6511","BK6092","AI","BK4587","BK4528","BK4023","01833","BK1515","BK1571","BK4543","BK1142","BK1247","BK1617","5RE.SI","BK4551","BK1219","BK4585","BK1615"],"gpt_icon":0},{"id":"2582101339","title":"Is JD Health International Inc. (HKG:6618) Expensive For A Reason? A Look At Its Intrinsic Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2582101339","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582101339?lang=en_us&edition=fundamental","pubTime":"2025-11-11 08:59","pubTimestamp":1762822783,"startTime":"0","endTime":"0","summary":"Key Insights Using the 2 Stage Free Cash Flow to Equity, JD Health International fair value estimate is HK$46.16 JD...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/4422000-choice1-main-header/1585186589176","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4422000-choice1-main-header/1585186589176"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-6618/jd-health-international-shares/news/is-jd-health-international-inc-hkg6618-expensive-for-a-reaso","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-6618/jd-health-international-shares/news/is-jd-health-international-inc-hkg6618-expensive-for-a-reaso","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["86618","FCF","HK0000320264.USD","BK4551","LU1880383366.USD","BK1247","BK4526","IE0008368742.USD","BK1591","BK4614","LU1688375341.USD","BK1571","BK1615","BK4558","IE00BGV7N243.SGD","SG9999002463.SGD","TV","BK4509","BK4100","06618","BK1142","LU0463099449.HKD","LU0326950275.SGD","BK4585","LU1188198961.HKD","LU0106959298.USD","LU0244354667.USD","BK1589","BK4531","SGXZ86797644.SGD","BK1583","HK0000306685.HKD","BK4503","BK4220","LU0307460666.USD","LU0588546209.SGD","BK4579","LU0051755006.USD","BK4122","BK4211","BK4504","BK4588","BK1515","SGXZ62798434.SGD","HK0000306701.USD","LU0456827905.SGD","DCF","HK0000320223.HKD"],"gpt_icon":1},{"id":"1111428562","title":"HK Stock Connect Shareholding Changes | Nov 11","url":"https://stock-news.laohu8.com/highlight/detail?id=1111428562","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111428562?lang=en_us&edition=fundamental","pubTime":"2025-11-11 08:38","pubTimestamp":1762821515,"startTime":"0","endTime":"0","summary":"According to disclosed data on November 10, 2025, Hao Tian International Construction (01341), Sinohytec (02402), and Tianli International Holdings (01773) recorded the largest increases in Stock...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00826","BK1539","HK0000252152.HKD","BK1594","LU0708995583.HKD","BK1126","IE0034224299.USD","02800","02587","BK1529","BK1576","03866","BK1161","01347","BK1583","BK1151","01709","BK1235","LU0320764599.SGD","BK1558","BK1241","02727","BK1515","BK1149","BK1147","09868","BK1110","BK1183","BK1197","00991","02050","BK1141","01951","MCHmain","LU0052750758.USD","LU0348825331.USD","01880","BK1554","02338","BK1171","BK1606","09885","SG9999014674.SGD","02402","BK1219","BK1607","BK1521","06865","LU0417516902.SGD","LU0588546209.SGD","01072","BK1597","BK1614","BK1224","BK1500","BK1596","BK1513","00553","IE00BZ08YR35.GBP","BK1560","LU0417516738.SGD","02865","BK1169","LU1794554557.SGD","02068","02157","00763","BK1119","BK1164","BK1129","BK1228","02255","BK1592","BK1170","BK1530","02837","02828","BK1225","00187","02533","BK1166","IE00BZ08YS42.EUR","01773","HK0000500386.USD","SG9999006597.SGD","BK1116","BK1588","06616","BK1175","00874","BK1163","BK1589","BK1546","BK1523","BK1506","SG9999003461.SGD","BK1202","LU0348735423.USD","BK1526","01282","00956","BK1237","LU0405327494.USD","00568","LU0593848301.USD","BK1522","IE00BZ08YT58.USD","06936","02648","BK1568","BK1575","02465","BK1236","BK1125","02273","LU0307460666.USD","03759","BK1556","BK1205","LU1808992512.USD","BK1587","LU0405327148.USD","BK1511","LU2213484517.USD","HK0000252160.HKD","01385","BK1567","00696","00358","02600","03800","BK1138","06680","BK1610","LU2543165471.USD","BK1505","BK1503","02208","02432","BK1564","09606","01071","06613","00525","06178","BK1206","06869","BK1191","00189","LU1720050803.USD","01341","BK1148"],"gpt_icon":1},{"id":"2582473802","title":"Ascletis Pharma (SEHK:1672) Is Up 5.5% After Revealing Promising Obesity Drug Updates at ObesityWeek 2025 Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2582473802","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582473802?lang=en_us&edition=fundamental","pubTime":"2025-11-11 01:27","pubTimestamp":1762795663,"startTime":"0","endTime":"0","summary":"Ascletis Pharma announced positive Phase Ib results for its ASC30 oral and subcutaneous formulations, showing notable placebo-adjusted mean body weight reduction, a favorable safety profile, and ultra-long half-lives supporting both monthly and quarterly dosing, with these updates presented recently at ObesityWeek 2025.\nThe company also unveiled new preclinical results where a combination of ASC47 and ASC31 outperformed monotherapies in promoting both weight and fat loss, and advanced its...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/ascletis-pharma-sehk1672-is-up-55-after-revealing-promising","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/ascletis-pharma-sehk1672-is-up-55-after-revealing-promising","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["01672","BK1161","BK1515","BK1574"],"gpt_icon":0},{"id":"2582587028","title":"BRIEF-Shanghai Junshi Biosciences Says As Of Nov 10 Chair Increased A Shares Shareholding","url":"https://stock-news.laohu8.com/highlight/detail?id=2582587028","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582587028?lang=en_us&edition=fundamental","pubTime":"2025-11-10 23:01","pubTimestamp":1762786883,"startTime":"0","endTime":"0","summary":"BRIEF-Shanghai Junshi Biosciences Says As Of Nov 10 Chair Increased A Shares Shareholding Nov 10  - Shanghai Junshi Biosciences Co Ltd 688180.SS:AS OF NOV 10  CHAIR INCREASED A SHARES SHAREHOLDING BY 100,000 SHARES TOTAL TRANSACTION AMOUNT AT RMB3.8 MILLIONFurther company coverage: 688180.SS ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nFWN3WM10I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK0239","BK1583","BK1515","01877","688180"],"gpt_icon":0},{"id":"2582772878","title":"Shanghai Junshi Biosciences - as of Nov 10  Chair Increased a Shares Shareholding by 100,000 Shares Total Transaction Amount at RMB3.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2582772878","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582772878?lang=en_us&edition=fundamental","pubTime":"2025-11-10 19:59","pubTimestamp":1762775960,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nFWN3WM10I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK0239","BK1583","BK1515","688180","01877"],"gpt_icon":0},{"id":"2582580822","title":"CSPC Pharmaceutical Group Board to Approve Third Quarter Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2582580822","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582580822?lang=en_us&edition=fundamental","pubTime":"2025-11-10 18:19","pubTimestamp":1762769986,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group Ltd. will hold a board meeting on Thursday, 20 November 2025 to approve, among other matters, the unaudited third quarter results of the company and its subsidiaries for the nine months ended 30 September 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CSPC Pharmaceutical Group Ltd. published the original content used to generate this news brief on November 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL4Ggtj2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093","BK1521","LU1813983027.USD","IE00B543WZ88.USD","SG9999004220.SGD","LU1328277881.USD","LU0067412154.USD","LU0140636845.USD","IE00BZ08YR35.GBP","LU0314109678.HKD","LU0880133367.SGD","LU1226288170.HKD","BK1515","HK0000165453.HKD","IE00B031HY20.USD","LU1993786604.SGD","LU1008478684.HKD","LU1226287792.SGD","IE00BZ08YT58.USD","IE0008368742.USD","LU1226287529.USD","IE00BZ08YS42.EUR","LU0326950275.SGD","LU1152091168.USD","LU1226288253.USD","IE00B5MMRT66.SGD","LU1960683339.HKD","LU2039709279.SGD","BK1191","LU0072913022.USD","LU1951186391.HKD","LU0501845795.SGD","LU1226287875.USD","LU1807302812.USD","LU1152091754.HKD","IE0008369823.USD","LU0315179316.USD"],"gpt_icon":0},{"id":"1192804019","title":"BYD Company Limited: Improved Per-Vehicle Profitability with Breakthroughs in Technology, Premiumization, and Exports","url":"https://stock-news.laohu8.com/highlight/detail?id=1192804019","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192804019?lang=en_us&edition=fundamental","pubTime":"2025-11-10 17:51","pubTimestamp":1762768302,"startTime":"0","endTime":"0","summary":"1. **Improved Per-Vehicle Profitability in Q3 Amid Easing Price Wars and Premiumization**      BYD reported Q3 2025 revenue of RMB 194.985 billion (-3.05% YoY, -2.95% QoQ), with net profit...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0505663152.USD","002594","LU1868837565.USD","LU0417516738.SGD","LU0348767384.USD","LU0823038988.USD","LU0348825331.USD","LU2097828714.EUR","LU0516422440.USD","LU0314109678.HKD","SG9999015952.SGD","LU2778985437.USD","LU0819121731.USD","LU2348774022.SGD","BK1582","LU0449515922.USD","LU1861219969.SGD","BK0196","LU0274383008.USD","LU0320764599.SGD","LU1813983027.USD","LU0469268626.HKD","LU0043850808.USD","LU0348735423.USD","LU0348805143.USD","LU2148510915.USD","BK1515","BK0183","LU2476274720.SGD","LU2097828557.USD","LU0588545904.SGD","SG9999006514.SGD","LU1242518857.USD","LU0244354667.USD","LU0588545490.SGD","LU1251922891.USD","LU1961090484.USD","LU0540923850.HKD","LU0511384066.AUD","LU2495084118.USD","LU1023057109.AUD","LU0164872284.USD","LU1242518931.SGD","LU0327786744.USD","BK0169","LU0289739343.SGD","LU1969619763.USD","LU1997244956.HKD","LU0865486749.SGD","LU1064130708.USD","LU2097828474.EUR","LU1880383440.USD","BK0014","LU1580142542.USD","LU2097828805.USD","BK0264","LU0823039010.USD","LU2399975544.HKD","LU0084288322.USD","SG9999006597.SGD","LU0348827113.USD","LU0828238088.HKD","BK1539","BK1149","BK1589","IE00BD6J9T35.USD","LU0164865239.USD","LU0823426308.USD","LU0229945570.USD","LU0054450605.USD","LU0214875030.USD","LU0823426480.USD","LU2328871848.SGD","BK0188","LU1868838027.USD","SG9999014674.SGD","LU0633140560.USD","LU0269904917.USD","LU0259732245.USD","LU2294711713.HKD","LU0823414478.USD","BK1119","LU0516423091.SGD","LU0650527681.SGD","LU1808992512.USD","LU0359201885.HKD","BK1607","LU1720050803.USD","LU0211977185.USD","LU0531970944.HKD","SG9999015986.USD","BK0072","LU1719994722.HKD","LU2039709279.SGD","LU0509642566.USD","01211","LU0594300179.USD","BYDDY","LU0463099449.HKD","LU0634319403.HKD","LU0856984785.SGD","81211","LU0143863784.USD","LU0633140727.USD","LU1508157978.USD","LU2357125470.USD","LU1997245177.USD","LU0561508036.HKD","LU1820825898.SGD","LU1303224171.USD","BK1610","LU2449936058.SGD","SG9999001226.SGD","LU2153592121.USD","LU0871576103.HKD","SG9999015945.SGD","LU2580892789.USD","LU2097828631.EUR","LU0708995583.HKD","LU0593848301.USD","LU1064131003.USD","LU1781817850.SGD","BK1504","LU0175139822.USD","LU1868837722.USD","LU0289961442.SGD","LU1188198961.HKD","00285","LU0326950275.SGD","BK1522","BK1509","EVS.SI","LU1770034418.SGD","BK1580","LU0819123356.HKD","BK0155","LU0516422366.SGD","LU1880383366.USD","BK0070","LU0516422952.EUR","LU0307460666.USD","LU1861214812.USD","SG9999002463.SGD","LU1146622755.USD","LU0417516902.SGD","LU0605514214.HKD","LU0683595622.HKD","LU0531971595.HKD","SG9999002828.SGD","LU0588546209.SGD","LU0165289439.USD","LU0516423174.USD","LU0594300419.USD","LU2249611893.SGD","LU0289960550.SGD","LU0572944931.SGD","LU0823414551.USD","LU0359202008.SGD","LU0052750758.USD","LU2476274308.USD","LU1794554557.SGD","LU0039217434.USD","LU1328277881.USD","LU1997245094.SGD","LU0143863198.USD","LU0979878070.USD","LU0315178854.USD","LU0588545730.USD","LU2506951792.HKD","LU0254981946.USD","LU2360107325.USD","HYDD.SI","SG9999015978.USD","LU0543330566.HKD","LU2580892862.HKD","LU2289578879.USD","LU0348766576.USD","BK1594","BK1540","LU0449509016.USD","LU0359201612.USD","LU2663582299.SGD"],"gpt_icon":1},{"id":"1139435082","title":"Ping An Implements \"Three Foundations, Four Supports\" Model to Empower Grassroots Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=1139435082","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139435082?lang=en_us&edition=fundamental","pubTime":"2025-11-10 16:41","pubTimestamp":1762764083,"startTime":"0","endTime":"0","summary":"The 8th Shenzhen General Practice Conference recently convened in Shenzhen, bringing together representatives from the China Community Health Association, grassroots health associations across 21...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01833","BK1515","BK1617","BK1247","BK1571","159891","BK1142","BK1219","BK1615"],"gpt_icon":0},{"id":"2582335825","title":"Sino Biopharmaceutical Stock Advances 1.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2582335825","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582335825?lang=en_us&edition=fundamental","pubTime":"2025-11-10 16:33","pubTimestamp":1762763580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. advanced 1.8% to 6.96 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.6% to 26649.06.Sino Biopharmaceutical Ltd. closed 24% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 2.7% and Amgen Inc. remained unchanged.Trading volume totaled 78.2 million shares, compared to the 50-day average of 119.4 million shares.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","BK1521","BK1191","01177","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","BK1515","BK1589"],"gpt_icon":0},{"id":"2582825890","title":"CSPC Pharmaceutical Group Stock Rises 2.7% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2582825890","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582825890?lang=en_us&edition=fundamental","pubTime":"2025-11-10 16:32","pubTimestamp":1762763520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. rose 2.7% to 7.58 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.6% to 26649.06.CSPC Pharmaceutical Group Ltd. closed 35% below its 52-week high of HK$11.63, which the company achieved Sept. 9.The stock outperformed some of its competitors, as Sino Biopharmaceutical Ltd. rose 1.8%, SSY Group Ltd. rose 1.0%, and United Laboratories International Holdings Ltd. fell 0.5%.Trading volume totaled 98.5 million shares, compared to the 50-day average of 157.0 million shares.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226288253.USD","LU0314109678.HKD","LU1226288170.HKD","LU1993786604.SGD","LU2039709279.SGD","BK1521","LU1226287529.USD","LU0501845795.SGD","LU0072913022.USD","LU1226287875.USD","IE00BZ08YT58.USD","LU0067412154.USD","IE00B5MMRT66.SGD","LU1807302812.USD","LU1960683339.HKD","01093","LU1328277881.USD","IE00BZ08YR35.GBP","BK1191","LU1813983027.USD","LU1152091168.USD","IE00BZ08YS42.EUR","SG9999004220.SGD","IE0008369823.USD","LU0880133367.SGD","IE0008368742.USD","LU0326950275.SGD","LU1951186391.HKD","LU1226287792.SGD","IE00B543WZ88.USD","LU0140636845.USD","LU1008478684.HKD","LU0315179316.USD","BK1515","HK0000165453.HKD","IE00B031HY20.USD","LU1152091754.HKD"],"gpt_icon":0},{"id":"2582823767","title":"JD Health International Stock Climbs 3.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2582823767","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582823767?lang=en_us&edition=fundamental","pubTime":"2025-11-10 16:30","pubTimestamp":1762763400,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. rose 3.3% to 61.45 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.6% to 26649.06.JD Health International Inc. closed 13% below its 52-week high of HK$70.40, which the company achieved Sept. 12.Trading volume totaled 4.7 million shares, compared to the 50-day average of 7.5 million shares.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4122","BK4504","BK1142","LU0051755006.USD","SGXZ62798434.SGD","LU0588546209.SGD","BK4503","LU1880383366.USD","BK1591","HK0000306685.HKD","SG9999002463.SGD","BK4505","BK1583","LU0244354667.USD","BK4526","HK0000320223.HKD","BK4585","BK4558","LU1688375341.USD","LU1188198961.HKD","LU0307460666.USD","LU0106959298.USD","BK4531","BK4220","BK1247","BK4551","HK0000320264.USD","IE00BGV7N243.SGD","SGXZ86797644.SGD","BK1571","BK4588","BK4579","86618","LU0326950275.SGD","BK1615","BK4509","IE0008368742.USD","LU0463099449.HKD","06618","BK4614","BK4524","LU0456827905.SGD","HK0000306701.USD","BK1589","BK1515"],"gpt_icon":1},{"id":"1166884046","title":"CMB International: Healthcare Sector Favors Stable Strategies, Opportunities in Undervalued Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1166884046","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166884046?lang=en_us&edition=fundamental","pubTime":"2025-11-10 13:50","pubTimestamp":1762753825,"startTime":"0","endTime":"0","summary":"CMB International released a research report highlighting a preference for stable investment strategies and opportunities in undervalued stocks. GUSHENGTANG (02273) announced a HK$300 million share...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2328871848.SGD","HK0000165453.HKD","02273","LU2097828474.EUR","01801","02367","BK1521","LU0455707207.USD","LU2097828714.EUR","BK1161","BK1191","IE00BZ08YR35.GBP","BK1141","BK1207","LU1969619763.USD","ORR","BK1574","SG9999004311.SGD","02268","BK1593","LU2097828805.USD","LU2488822045.USD","01177","BK1219","BK1589","LU2242644610.SGD","IE00BZ08YT58.USD","SG9999014674.SGD","BK1583","LU2097828631.EUR","BK1515","LU0502904849.HKD","LU2097828557.USD","IE00BZ08YS42.EUR","01530","06978"],"gpt_icon":0},{"id":"2582849801","title":"CanSino Biologics to Use Reserves to Offset Accumulated 1.45 Billion Yuan Losses; Shares Gain 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582849801","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582849801?lang=en_us&edition=fundamental","pubTime":"2025-11-10 13:09","pubTimestamp":1762751360,"startTime":"0","endTime":"0","summary":"CanSino Biologics  said it plans to use its capital and surplus reserves to fully offset accumulated losses of 1.45 billion yuan as of Dec. 31, 2024, according to a Nov. 7 Hong Kong bourse filing.Shares of the firm rose 3% in Monday's midday trade.The plan calls for using 118.4 million yuan of surplus reserves and 1.33 billion yuan of capital reserves, both derived from share premiums, to eliminate the parent company's accumulated losses.After the adjustment, CanSino's surplus reserve will fall to zero, while its capital reserve will decline to 5.24 billion yuan.The proposal, approved by the board, will be subject to shareholder approval at an upcoming extraordinary general meeting.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1515","06185","BK1191","BK1574","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":3,"totalSize":180,"code":"91000000","status":"200"}]}}